Velindre’s PATHOS Trial, which is looking to develop less toxic treatments for patients with Human Papillomavirus (HPV) associated Head and Neck Cancer
, is proudly led by VCC Consultant, Professor Mererid Evans (along with Professor Terry Jones from the University of Liverpool) and is co-sponsored by Velindre NHS Trust and Cardiff University. The study is currently open in 34 UK sites and has recruited over 400 patients over the last 4 years.
This is a very exciting time for PATHOS as it is now opening internationally - a centre in Florida, USA recruited the 1st international patient to PATHOS on 25 May 2020!
We are on track to open a centre in Brisbane, Australia in August 2020 and centres across France in September 2020. We also plan to open sites in Germany and other European countries later this year, which is incredible for a Clinical Trial that started here at Velindre.
Find out more about this fantastic trial here;
Source: Velindre Cancer Centre